Advertisement
YOU ARE HERE: LAT HomeCollectionsRoth Capital Partners
IN THE NEWS

Roth Capital Partners

FEATURED ARTICLES
BUSINESS
February 13, 2001 | Associated Press
Zions First National Bank confirmed Monday that it is buying a 24.5% stake in Roth Capital Partners LLC, a Newport Beach investment firm specializing in small and mid-size high-tech stock offerings. The Salt Lake City bank, a subsidiary of Zions Bancorporation, said it will pay $16.5 million to become the second-largest shareholder behind Roth Capital's chairman, Byron Roth, who will remain the majority shareholder. Zions will not have a seat on Roth Capital's board.
ARTICLES BY DATE
BUSINESS
February 13, 2001 | Associated Press
Zions First National Bank confirmed Monday that it is buying a 24.5% stake in Roth Capital Partners LLC, a Newport Beach investment firm specializing in small and mid-size high-tech stock offerings. The Salt Lake City bank, a subsidiary of Zions Bancorporation, said it will pay $16.5 million to become the second-largest shareholder behind Roth Capital's chairman, Byron Roth, who will remain the majority shareholder. Zions will not have a seat on Roth Capital's board.
Advertisement
BUSINESS
January 15, 2002 | Bloomberg News
Miravant Medical Technologies shares sank 75% after the company said its leading product, a drug to treat a major cause of blindness, failed to work in a late-stage study. Santa Barbara-based Miravant is an unprofitable company that specializes in light-activated drugs and has no other products ready for the market. Its shares dropped $7.31 to $2.44 in Nasdaq trading of 13.6 million shares, about 140 times the three-month daily average. Miravant's decline was the biggest on U.S. markets.
BUSINESS
May 26, 2004 | From Times Staff Reports
Money manager Euro Pacific Capital of Newport Beach said Tuesday that it had bought the international brokerage division of rival Roth Capital Partners, another Newport Beach firm. Euro Pacific said the deal would bring it about 1,700 new clients and nearly $100 million in assets, boosting its total assets to more than $350 million. Euro Pacific, headed by Peter Schiff, focuses primarily on foreign investing. Schiff is well known for being bearish on U.S. assets. He believes the large U.S.
BUSINESS
February 19, 2000 | Dow Jones
Newport Beach investment banking firm Cruttenden Roth Inc. said Friday that it will change its name to Roth Capital Partners Inc. to reflect changes in its management. The company's founder, Walter Cruttenden III, departed two years ago, and Byron Roth, the chief executive, has taken control of the company. Roth is expected to announce the name change Tuesday at the company's 12th annual growth stock investment conference.
BUSINESS
February 12, 2001 | Associated Press
Zions First National Bank is expected to announce today that it is buying a 24.5% stake in Roth Capital Partners, a Newport Beach-based investment firm specializing in high-tech stock offerings. Salt Lake City-based Zions will pay $16.5 million, making it the No. 2 shareholder, though Zions will have no seat on Roth's board. Byron Roth, the company's chairman and chief executive, will remain the majority shareholder.
BUSINESS
February 21, 2001
Newport Corp., which only last month lowered its revenue projections for the year, said late Tuesday it plans to generate more than $420 million in sales--far exceeding its highest forecast. The Irvine maker of precision components and instruments said in a press release that the 66% sales increase is being driven by a greater number of orders that also will boost income. Newport had initially indicated it expected sales to grow 50% this year over $252.9 million last year.
BUSINESS
March 7, 2000 | Bloomberg News
Shares of NeoRx Corp., a Seattle biotechnology company working on ways to improve radiation treatment of cancer, more than doubled Monday after a medical journal said the firm's technology cured cancer in certain mice. The stock (ticker symbol: NERX) jumped $32.94 to close at $54.75 on Nasdaq, and pumped up other biotech shares as well. On Nasdaq, Imclone Systems (IMCL) surged $14.69 to $169.13, and Visible Genetics (VGIN) gained $11.50 to $110.
BUSINESS
August 23, 2000 | Reuters
Shares of Ameritrade Holding Corp. (AMTD) rallied Tuesday amid talk of a possible sale of the No. 5 U.S. Internet brokerage. "We hear that there's a rumor of a potential acquisition by American Express [AXP]," said Robertson Stephens analyst Scott Appleby. Officials from Ameritrade were not immediately available for comment, and a spokeswoman for American Express Co., which already has an online brokerage operation, said the company does not comment on market speculation or rumors.
BUSINESS
July 28, 2004 | Julie Tamaki, Times Staff Writer
Rubio's Restaurants Inc. reported Tuesday that its new menu, stronger sales and operational improvements helped it post a second-quarter profit, reversing a year-earlier loss. The Carlsbad, Calif.-based chain of 151 Mexican grill restaurants best known for fish tacos earned $1.2 million, or 13 cents a share, contrasted with a loss of $3.1 million, or 35 cents, a year earlier. Analysts had forecast 9 cents a share, according to a survey by Thomson First Call.
BUSINESS
September 25, 2012 | Bloomberg News
Peregrine Pharmaceuticals Inc. plunged the most ever after the biotechnology company said the survival rates from its lung cancer study reported earlier this month were unreliable. Peregrine, based in Tustin, declined 74% to $1.42 at 10:12 a.m. New York time, after falling as low as 80 cents in its biggest intraday drop since the stock began trading in 1994. The shares of the company had more than quadrupled in the past 12 months through last week. Peregrine had soared 47% on Sept.
Los Angeles Times Articles
|